FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Patel Samir Rashmikant
2. Date of Event Requiring Statement (MM/DD/YYYY)
4/17/2020 

3. Issuer Name and Ticker or Trading Symbol

CytoDyn Inc. [CYDY]
(Last)        (First)        (Middle)

1111 MAIN STREET, SUITE 660
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__X__ Director                          _____ 10% Owner
_____ Officer (give title below)        _____ Other (specify below)
(Street)

VANCOUVER, WA 98660      

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed(MM/DD/YYYY)
4/22/2020 

6. Individual or Joint/Group Filing(Check Applicable Line)

_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock 7218874 I By LLC 

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Warrant 5/22/2018 5/22/2023 Common Stock 1300000 $0.75 I By LLC 
Warrant 8/28/2018 8/28/2023 Common Stock 500000 $0.75 I By LLC 
Warrant 8/31/2018 8/31/2023 Common Stock 250000 $0.75 I By LLC 
Warrant 9/6/2018 9/6/2023 Common Stock 100000 $0.75 I By LLC 
Warrant 12/11/2018 12/11/2023 Common Stock 150000 $0.75 I By LLC 

Explanation of Responses:

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
Patel Samir Rashmikant
1111 MAIN STREET
SUITE 660
VANCOUVER, WA 98660
X



Signatures
Arian Colachis, Attorney-in-fact4/22/2020
**Signature of Reporting PersonDate

CytoDyn (QB) (USOTC:CYDY)
Historical Stock Chart
From Apr 2020 to May 2020 Click Here for more CytoDyn (QB) Charts.
CytoDyn (QB) (USOTC:CYDY)
Historical Stock Chart
From May 2019 to May 2020 Click Here for more CytoDyn (QB) Charts.